Added to YB: 2026-01-22
Pitch date: 2026-01-20
GXI.DE [neutral]
Gerresheimer AG
-17.55%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
Gerresheimer AG, together with its subsidiaries, provides medicine packaging, drug delivery devices, and solutions in Germany and internationally.
Market Cap
EUR 888.4M
Pitch Price
EUR 25.30
Price Target
N/A
Dividend
0.16%
EV/EBITDA
7.63
P/E
38.05
EV/Sales
1.37
Sector
Life Sciences Tools and Services
Category
turnaround
Gerresheimer (GXI Germany): turning the corner
GXI.DE (overview): Pharma packaging co emerging from 2025 drags as oral liquids/cosmetics/vials stabilize. Mgmt targets low single-digit organic growth 2026 vs mid-single digit decline 2025. Improved transparency coming; moulded glass divestment delayed til H2 2026+ for better valuation. Focus shifted to margins/cash vs revenue growth.
Read full article (2 min)